Correlation Between BRIM Biotechnology and Medigen Biotechnology
Can any of the company-specific risk be diversified away by investing in both BRIM Biotechnology and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BRIM Biotechnology and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BRIM Biotechnology and Medigen Biotechnology, you can compare the effects of market volatilities on BRIM Biotechnology and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BRIM Biotechnology with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of BRIM Biotechnology and Medigen Biotechnology.
Diversification Opportunities for BRIM Biotechnology and Medigen Biotechnology
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between BRIM and Medigen is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding BRIM Biotechnology and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and BRIM Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BRIM Biotechnology are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of BRIM Biotechnology i.e., BRIM Biotechnology and Medigen Biotechnology go up and down completely randomly.
Pair Corralation between BRIM Biotechnology and Medigen Biotechnology
Assuming the 90 days trading horizon BRIM Biotechnology is expected to under-perform the Medigen Biotechnology. In addition to that, BRIM Biotechnology is 1.08 times more volatile than Medigen Biotechnology. It trades about -0.31 of its total potential returns per unit of risk. Medigen Biotechnology is currently generating about -0.21 per unit of volatility. If you would invest 3,695 in Medigen Biotechnology on August 30, 2024 and sell it today you would lose (205.00) from holding Medigen Biotechnology or give up 5.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
BRIM Biotechnology vs. Medigen Biotechnology
Performance |
| Timeline |
| BRIM Biotechnology |
| Medigen Biotechnology |
BRIM Biotechnology and Medigen Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BRIM Biotechnology and Medigen Biotechnology
The main advantage of trading using opposite BRIM Biotechnology and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BRIM Biotechnology position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.| BRIM Biotechnology vs. Taiwan Semiconductor Manufacturing | BRIM Biotechnology vs. Hon Hai Precision | BRIM Biotechnology vs. MediaTek | BRIM Biotechnology vs. Chunghwa Telecom Co |
| Medigen Biotechnology vs. Sinphar Pharmaceutical Co | Medigen Biotechnology vs. Grape King Bio | Medigen Biotechnology vs. Apex Biotechnology Corp | Medigen Biotechnology vs. Leatec Fine Ceramics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |